Announcement
12 February 2025
Member focus

ATOM Coalition partners with ACT for Children to bridge childhood cancer medicine gaps in LMICs

UICC welcomes the launch of the Access Cancer Treatment (ACT) for Children initiative, which aims to address the disparities in childhood cancer care in low- and middle-income countries (LMICs). 

Woman with dark hair in Mongolia with a bald child, cancer patient, on her shoulders

The Access Cancer Treatment (ACT) for Children initiative is a step closer towards children gaining more access to high-quality, life-saving cancer medicines, alongside essential clinical care and patient support. It brings together a number of UICC members and partners: Childhood Cancer International (CCI), IDA Foundation, the International Society of Paediatric Oncology (SIOP), Resonance, World Child Cancer and Servier. The collaboration builds on the approach of the UICC-led ATOM Coalition in increasing access to oncology medicines in low and middle-income countries (LMICs), reinforcing partners' commitment to sustainable cancer care solutions. 

Supported by the ATOM Coalition, the initiative has already delivered USD 2.3 million worth of innovative paediatric oncology medicines to cancer centres in Asia and Central America, with plans to extend its reach to additional regions. 

“For children in LMICs, access to quality cancer treatment remains a major challenge. The ATOM Coalition provides a vital platform for collective action, working with pharmaceutical partners and local stakeholders to reduce financial and logistical barriers. We are proud to collaborate with ACT for Children and other key partners to drive meaningful progress in paediatric cancer care.”
– Amy Israel, Senior Advisor, Access to Medicines, UICC-led ATOM Coalition. 

The joint efforts align with the WHO's Global Initiative for Childhood Cancer, which aims to increase child cancer survival rates to at least 60% globally by 2030, potentially saving the lives of an additional one million children and with the WHO CureAll framework to ensure a holistic approach to sustainable and comprehensive paediatric cancer treatment.

Over the next year, ATOM Coalition partners and ACT for Children will continue to advocate for stricter regulations on counterfeit and substandard medicines, expand educational programs for healthcare providers in LMICs, scale up medicine distribution efforts to additional cancer centres and support local health systems through capacity-strengthening initiatives. 
Tags ATOM Coalition Members & Partners Access to Medicines Essential medicines People-centred care Member focus

Last update

Friday 14 February 2025

Share this page

Related content

Middle-aged Asian woman and Caucasian man speaking at a conference, sitting on a couch facing the moderator

The new Executive Director of the Access to Oncology Medicines (ATOM) Coalition, Natasha Shah, outlines the work ahead to expand access to cancer care in low- and lower-middle-income countries through local partnerships, capacity-strengthening and effective pathways to innovative medicines.
Close up of a hand of a hospital patient receiving IV antibiotics

Marking Universal Health Coverage (UHC) Day on 12 December, Sarbani of the UICC-led Access to Oncology Medicines (ATOM) Coalition writes about how innovative health financing strategies could transform access and equity under UHC in LMICs that face critical gaps in cancer care financing.